Recurrent Primary Mediastinal Large B-Cell Lymphoma
8 clinical trials · Condition
◉ Watch Recurrent Primary Mediastinal Large B-Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Copanlisib Hydrochloride and Nivolumab in Treating Patients With Recurrent or Refractory Diffuse Large B-cell Lymphoma or Primary Mediastinal Large B-cell Lymphoma (NCT03484819) | National Cancer Institute (NCI) | 2019-12-13 |
| Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas (NCT03038672) | National Cancer Institute (NCI) | 2018-12-21 |
Track Recurrent Primary Mediastinal Large B-Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.